FilingSEC EDGAR8-K
Aptevo Therapeutics Announces Annual Meeting Results
· SEC accepted
StageCompleted
Filing content
The company approved the election of directors, appointment of auditors, executive compensation, and the amended stock incentive plan at its annual meeting.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…